Diasome Pharmaceuticals

This year has posed substantial challenges for global markets: a prolonged period of high interest rates, ongoing geopolitical instability, democratic uncertainty, and an unprecedented number of natio

The final installment of Scrip ’s round-up of industry insiders’ views of the big issues that will shape 2020 focuses on one figure that was a recurring theme among the 80+ people we spoke to: the pa

The most noteworthy aspect of the US Food & Drug Administration’s 13 May hearing on the pathway for biosimilar insulin may have been the very limited number of sponsors who chose to present. Of the th

It has never been a better time for life sciences start-ups to raise money from venture sources. In 2017, according to data compiled by Informa Pharma Intelligence, venture capitalists invested a tota